PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration

PLCG2 is lowly expressed in LUAD tissues and is involved in immune infiltration of LUAD, inhibiting LUAD cell proliferation and metastasis.

Authors

Institutions

Publication Details

Journal
Current Cancer Drug Targets
Published
2024-08-23
DOI
https://doi.org/10.2174/0115680096307100240801095132
Citations
4
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration

Yuxin Chen, Yumin Wang, Qingqing Xu, Caihong Wang et al.
4 citations
Current Cancer Drug Targets
PI3K/AKT/mTOR signaling in cancer
0.94
article

PLCG2, A Regulator of Lung Adenocarcinoma Proliferation and Migration Associated with Immune Infiltration

Yuxin Chen, Yumin Wang, Qingqing Xu, Caihong Wang, Shuhui Chen, Jieying Dai, Zhaoting Hu, Chenkang Zhou
article en
4 citations

Abstract

PLCG2 is lowly expressed in LUAD tissues and is involved in immune infiltration of LUAD, inhibiting LUAD cell proliferation and metastasis.

Current Cancer Drug TargetsVol. 25(2)
Wenzhou Medical University (CN), First Affiliated Hospital of Wenzhou Medical University (CN), Blood Center of Zhejiang Province (CN)
Health Commission of Zhejiang Province
Openalex Percentile: Top 26%
PI3K/AKT/mTOR signaling in cancer
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.